294 related articles for article (PubMed ID: 19663648)
1. Targeting the IGF1 axis in cancer proliferation.
Bruchim I; Attias Z; Werner H
Expert Opin Ther Targets; 2009 Oct; 13(10):1179-92. PubMed ID: 19663648
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer.
Werner H
Oncogene; 2012 May; 31(22):2703-14. PubMed ID: 21963847
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.
Tao Y; Pinzi V; Bourhis J; Deutsch E
Nat Clin Pract Oncol; 2007 Oct; 4(10):591-602. PubMed ID: 17898809
[TBL] [Abstract][Full Text] [Related]
5. Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.
Hendrickson AW; Haluska P
Curr Opin Investig Drugs; 2009 Oct; 10(10):1032-40. PubMed ID: 19777391
[TBL] [Abstract][Full Text] [Related]
6. Development of molecular agents for IGF receptor targeting.
Salisbury AJ; Macaulay VM
Horm Metab Res; 2003; 35(11-12):843-9. PubMed ID: 14710367
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
Werner H; Maor S
Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
[TBL] [Abstract][Full Text] [Related]
8. Implications of insulin-like growth factor-I for prostate cancer therapies.
Kojima S; Inahara M; Suzuki H; Ichikawa T; Furuya Y
Int J Urol; 2009 Feb; 16(2):161-7. PubMed ID: 19183230
[TBL] [Abstract][Full Text] [Related]
9. Targeting IGF-1 signaling pathways in gynecologic malignancies.
Bruchim I; Werner H
Expert Opin Ther Targets; 2013 Mar; 17(3):307-20. PubMed ID: 23294364
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H; Wesseling J; Boezen HM; van der Graaf WT
Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
[TBL] [Abstract][Full Text] [Related]
11. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.
Tognon CE; Sorensen PH
Expert Opin Ther Targets; 2012 Jan; 16(1):33-48. PubMed ID: 22239439
[TBL] [Abstract][Full Text] [Related]
12. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.
Yakar S; Leroith D; Brodt P
Cytokine Growth Factor Rev; 2005; 16(4-5):407-20. PubMed ID: 15886048
[TBL] [Abstract][Full Text] [Related]
13. Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells.
Zhang H; Sachdev D; Wang C; Hubel A; Gaillard-Kelly M; Yee D
Breast Cancer Res Treat; 2009 Mar; 114(2):277-85. PubMed ID: 18418709
[TBL] [Abstract][Full Text] [Related]
14. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.
Hofmann F; García-Echeverría C
Drug Discov Today; 2005 Aug; 10(15):1041-7. PubMed ID: 16055020
[TBL] [Abstract][Full Text] [Related]
15. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer.
Werner H; Shalita-Chesner M; Abramovitch S; Idelman G; Shaharabani-Gargir L; Glaser T
Mol Genet Metab; 2000; 71(1-2):315-20. PubMed ID: 11001824
[TBL] [Abstract][Full Text] [Related]
17. Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1).
Giannini S; Benvenuti S; Luciani P; Manuelli C; Cellai I; Deledda C; Pezzatini A; Vannelli GB; Maneschi E; Rotella CM; Serio M; Peri A
J Endocrinol; 2008 Sep; 198(3):523-32. PubMed ID: 18612048
[TBL] [Abstract][Full Text] [Related]
18. IGF1R signalling and its inhibition.
Riedemann J; Macaulay VM
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S33-43. PubMed ID: 17259557
[TBL] [Abstract][Full Text] [Related]
19. Targeting the insulin-like growth factor axis for the development of novel therapeutics in oncology.
Gao J; Chang YS; Jallal B; Viner J
Cancer Res; 2012 Jan; 72(1):3-12. PubMed ID: 22215692
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor-I receptor as an oncogene.
Werner H; Bruchim I
Arch Physiol Biochem; 2009 May; 115(2):58-71. PubMed ID: 19485702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
